Altrius Capital Management Inc Novartis Ag Transaction History

Altrius Capital Management Inc

$390 Million
Q3 2024

A detailed history of Altrius Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Altrius Capital Management Inc holds 74,438 shares of NVS stock, worth $7.33 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares

74,438

Previous 78,060 4.64%

Holding current value

$7.33 Million

Previous $8.31 Million 3.02%

% of portfolio

2.2%

Previous 2.23%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$106.13 - $120.89 $384,402 - $437,863	-3,622 Reduced 4.64%	74,438 $8.56 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $123,951 - $143,768	1,339 Added 1.75%	78,060 $8.31 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $658,601 - $749,853	6,913 Added 9.9%	76,721 $7.42 Million
Q4 2023 Feb 05, 2024	SELL	$92.27 - $101.54 $20,299 - $22,338	-220 Reduced 0.31%	69,808 $7.05 Million
Q3 2023 Oct 30, 2023	SELL	$94.73 - $105.13 $47,933 - $53,195	-506 Reduced 0.72%	70,028 $7.13 Million
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $67,354 - $76,374	-728 Reduced 1.02%	70,534 $7.12 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $318,359 - $369,198	3,978 Added 5.91%	71,262 $6.56 Million
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $162,205 - $198,640	2,147 Added 3.3%	67,284 $6.1 Million
Q3 2022 Nov 08, 2022	BUY	$74.61 - $87.26 $1.2 Million - $1.41 Million	16,108 Added 32.85%	65,137 $4.95 Million
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $3.95 Million - $4.6 Million	49,029 New	49,029 $4.14 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrius Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altrius Capital Management Inc with notifications on news.

Account

Altrius Capital Management Inc Novartis Ag Transaction History